|
|
Article: AstraZeneca's Zomig nasal spray provides fast migraine relief.
- Article from:
- Pharma Marketletter
- Article date:
- June 30, 2003
CopyrightCOPYRIGHT 2003 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
AstraZeneca's Zomig (zolmitriptan) nasal spray provides significant relief from migraine in just 10 minutes, according to findings from the REALIZE (REAl Life Intranasal Zolmitriptan Experience) study involving 912 patients. In the trial, significantly more ...
Related newspaper, magazine, and journal articles:
|
|
Article: FDA clears AstraZeneca's Zomig nasal spray.
Pharma Marketletter;
October 13, 2003 ;
343 words
... ... decision was based on a pivotal trial in which 5mg Zomig nasal spray produced a significant headache response at 15 minutes ... treated with the product. "The FDA's approval of Zomig nasal spray is a very important step forward for migraine sufferers ...
|
|